{
"@context": "/terms/",
"@id": "/human-beta-cell-line/PKBSM5907VASA/",
"@type": [
"HumanBetaCellLines",
"Biosample",
"Sample",
"Item"
],
"accession": "PKBSM5907VASA",
"age": "unknown",
"audit": {
"INTERNAL_ACTION": [
{
"category": "upgrade failure",
"detail": "VersionTooHigh('Award', '6', '5') upgrading from '6' to '5'",
"level": 30,
"level_name": "INTERNAL_ACTION",
"name": "audit_item_schema",
"path": "/awards/U24DK138512/"
}
],
"WARNING": [
{
"category": "incorrect classifications format",
"detail": "Human beta cell line [PKBSM5907VASA](/human-beta-cell-line/PKBSM5907VASA/) has `classifications` ['human beta cell line'] but should be [\"cell line\"]. Human beta cell lines are expected to have classifications as an array.",
"level": 40,
"level_name": "WARNING",
"name": "audit_classifications_format_check",
"path": "/human-beta-cell-line/PKBSM5907VASA/"
}
]
},
"authentication": "not provided",
"award": {
"@id": "/awards/U24DK138512/",
"component": "data coordination"
},
"classifications": [
"human beta cell line"
],
"coating_condition": "Matrigel-fibronectin",
"creation_timestamp": "2025-10-01T02:54:49.114344+00:00",
"description": "EndoC-bH1 cells treated with IFNa for 24hr from GSE133218",
"donors": [
{
"@id": "/human-donors/PKBDO8293TLPA/",
"accession": "PKBDO8293TLPA",
"age": 0,
"summary": "PKBDO8293TLPA",
"taxa": "Homo sapiens"
}
],
"file_sets": [
{
"@id": "/analysis-sets/PKBDS8682VUMC/",
"accession": "PKBDS8682VUMC",
"aliases": [
"pankbase-consortium:EndoC-bH1_treated_IFNa24hr_GSE133218_AnalysisSet"
],
"lab": {
"title": "Pankbase Consortium, PanKbase"
},
"status": "released",
"summary": "intermediate analysis of RNA-seq data"
},
{
"@id": "/measurement-sets/PKBDS8443OBOR/",
"accession": "PKBDS8443OBOR",
"aliases": [
"pankbase-consortium:EndoC-bH1_treated_IFNa24hr_GSE133218_MeasurementSet"
],
"assay_term": {
"term_name": "bulk RNA-seq assay"
},
"lab": {
"title": "Pankbase Consortium, PanKbase"
},
"status": "released",
"summary": "bulk RNA-seq assay (RNA-seq)"
}
],
"growth_medium": " DMEM containing 5.6 mmol/l glucose, 2% BSA fraction V, fatty acid free, 50 μmol/l 2mercaptoethanol, 10 mmol/l nicotinamide, 5.5 μg/ml transferrin, 6.7 ng/ml selenite, 100 units/ml penicillin and 100 μg/ml streptomycin",
"institutional_certificates": [],
"lab": {
"@id": "/labs/kyle-gaulton/",
"title": "Kyle Gaulton, UCSD"
},
"multiplexed_in": [],
"origin_of": [],
"parts": [],
"pooled_in": [],
"publication_identifiers": [
"PMID:32444635"
],
"release_timestamp": "2025-01-10T01:34:34.487993+00:00",
"sample_name": "EndoC-bH1",
"sample_terms": [
{
"@id": "/sample-terms/CVCL_909/",
"term_name": "EndoC-βH1"
}
],
"schema_version": "20",
"sorted_fractions": [],
"sources": [
{
"@id": "/sources/r-scharfmann-university-of-paris-france/",
"title": "R. Scharfmann, University of Paris, France"
}
],
"status": "released",
"submitted_by": {
"@id": "/users/7e95dcd6-9c35-4082-9c53-09d14c5752be/",
"title": "Parul Kudtarkar"
},
"summary": "EndoC-βH1 cell line, treated with 2000 U/mL Interferon alpha-2 for 86400 seconds",
"taxa": "Homo sapiens",
"treatments": [
{
"@id": "/treatments/ff4d301b-35c2-42df-a783-2ce9ec639f22/",
"purpose": "stimulation",
"status": "released",
"summary": "Treatment of 2000 U/mL Interferon alpha-2 for 86400 seconds",
"treatment_type": "protein"
}
],
"uuid": "1d216d0f-9bdb-415f-b719-ae276af4cfbc",
"virtual": false
}